Recently, WBL Medical Technology officially announced the launch of its global expansion strategy, with Malaysia as the first stop in its overseas market. The company aims to promote its revolutionary male health solution—the Low-Intensity Pulsed Ultrasound (LIPUS) treatment technology. This move not only further solidifies WBL's leading position in the field of erectile dysfunction (ED) treatment but also injects new vitality into the global healthcare industry upgrade.

The WBL delegation visited several key hospitals in Selangor and Melaka, where the hospital representatives expressed strong interest in the WBL LIPUS treatment system and reached preliminary strategic cooperation agreements. This friendly and cordial exchange marks the first step in WBL's international expansion and signifies the deep connection between its innovative medical technology and Southeast Asia's healthcare needs.

Traditional ED treatments often rely on medication or surgery, while WBL's self-developed LIPUS technology, with its three significant advantages—non-invasive, high safety, and long-lasting effects—fills a gap in the ED treatment field. The technology uses low-intensity pulsed ultrasound to precisely target the affected area, effectively promoting blood vessel regeneration and tissue repair, thereby significantly improving erectile function. The introduction of this innovative technology will undoubtedly bring new treatment options and hope to ED patients in Malaysia.

During the visit, the WBL delegation deeply felt the local hospitals' strong desire and pursuit for advanced medical technologies. The hospital representatives understood that the introduction of WBL's LIPUS technology would greatly enhance the local medical standards and service quality, offering ED patients a more efficient, privacy-first treatment option. As a result, the hospitals expressed their willingness to cooperate with WBL, looking forward to jointly promoting the widespread use and application of the LIPUS technology in Malaysia.

The collaboration between WBL and Malaysian hospitals will usher in a new era of male health. As WBL's LIPUS technology is widely promoted and applied in Malaysia, more and more ED patients will be able to benefit from this advanced treatment technology.

Meanwhile, WBL will continue to increase its investment in the Malaysian market through technology transfer, expert training, and equipment coordination, building a more comprehensive medical service system and providing patients with full-scale, personalized diagnostic and treatment services.

In addition, WBL will actively seek partnerships with more international collaborators to jointly promote the global popularization and application of LIPUS technology. By sharing medical resources and fostering technological exchange and cooperation, WBL aims to provide more accurate and efficient diagnostic and treatment solutions for patients worldwide, advancing the global healthcare cause together.